Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Macular Telangiectasia”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Not applicableStudy completedNCT03321916
What this trial is testing

MacTel Laser Study

Who this might be right for
Macular Telangiectasia
The Lowy Medical Research Institute Limited 9
Testing effectiveness (Phase 2)Study completedNCT00504400
What this trial is testing

Ranibizumab to Treat Type 2 Idiopathic Macular Telangiectasia (RAMA-Trial)

Who this might be right for
Type 2 Idiopathic Macular Telangiectasia
University Hospital, Bonn 10
Large-scale testing (Phase 3)Ended earlyNCT03845049
What this trial is testing

Comparative Multicenter Randomized Study of Aflibercept Versus Placebo in Macular Telangiectasia Type 1

Who this might be right for
Macular Telangiectasia
Centre Hospitalier Universitaire Dijon 16
Early research (Phase 1)Study completedNCT00685854
What this trial is testing

Ranibizumab Injections to Treat Macular Telangiectasia Without New Blood Vessel Growth

Who this might be right for
Macular Telangiectasia
National Eye Institute (NEI) 5
Not applicableLooking for participantsNCT00874783
What this trial is testing

Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases

Who this might be right for
Neurodegenerative Disorders
Hadassah Medical Organization 120
Large-scale testing (Phase 3)Not Yet RecruitingNCT07342439
What this trial is testing

Study of Serine Supplementation to Protect Vision in MacTel

Who this might be right for
Macular Telangiectasia Type 2 (MacTel)
The Lowy Medical Research Institute Limited 120
Early research (Phase 1)Study completedNCT00685503
What this trial is testing

Ranibizumab Injections to Treat Macular Telangiectasia With New Blood Vessel Growth

Who this might be right for
Neovascularization
National Eye Institute (NEI) 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT04907084
What this trial is testing

Serine and Fenofibrate Study in Patients With MacTel Type 2

Who this might be right for
Macular Telangiectasia Type 2
The Lowy Medical Research Institute Limited 60
Testing effectiveness (Phase 2)Study completedNCT03669393
What this trial is testing

Evaluate THR-317 Treatment for Macular Telangiectasia Type 1 (MacTel 1)

Who this might be right for
Retinal TelangiectasisIdiopathic Juxtafoveal Retinal Telangiectasia
ThromboGenics 8
Testing effectiveness (Phase 2)UnknownNCT01975103
What this trial is testing

Non-damaging Retinal Laser Therapy With PASCAL Laser for Macular Diseases

Who this might be right for
Diabetic Macular EdemaBranch Retinal Vein OcclusionChronic Central Serous Retinopathy+1 more
Federal University of Rio Grande do Sul 20
Testing effectiveness (Phase 2)Study completedNCT01205035
What this trial is testing

High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia

Who this might be right for
Retinal DiseasesTelangiectasis
Eye Center of Northern Colorado, P.C. 6
Large-scale testing (Phase 3)Study completedNCT00451763
What this trial is testing

Intravitreal Bevacizumab for Idiopathic Macular Telangiectasia

Who this might be right for
RetinaTelangiectasis
University of Sao Paulo 31
Early research (Phase 1)Study completedNCT00457145
What this trial is testing

Injected Ranibizumab to Treat Macular Telangiectasia Without New Blood Vessel Formation

Who this might be right for
Telangiectasia
National Eye Institute (NEI) 5
Large-scale testing (Phase 3)Study completedNCT03316300
What this trial is testing

Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol A

Who this might be right for
Macular Telangiectasia Type 2 (MacTel)
Neurotech Pharmaceuticals 120
Post-approval studies (Phase 4)Looking for participantsNCT06971939
What this trial is testing

Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants

Who this might be right for
Macular Telangiectasia Type 2 (MacTel)
Neurotech Pharmaceuticals 285
Testing effectiveness (Phase 2)Study completedNCT00470977
What this trial is testing

Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy

Who this might be right for
Coats' DiseaseIdiopathic Retinal TelangiectasiaRetinal Angiomatous Proliferation+7 more
Manhattan Eye, Ear & Throat Hospital 18
Large-scale testing (Phase 3)Active Not RecruitingNCT06397131
What this trial is testing

Determine the Safety and Efficacy of NT-501 With MHFM

Who this might be right for
Macular Telangiectasia Type 2
Neurotech Pharmaceuticals 12
Early research (Phase 1)Study completedNCT00457067
What this trial is testing

Injected Ranibizumab to Treat Macular Telangiectasia With New Blood Vessel Formation

Who this might be right for
Telangiectasia
National Eye Institute (NEI) 5
Not applicableStudy completedNCT01354093
What this trial is testing

The Role of Macular Pigment Carotenoids in the Pathogenesis and Treatment of Macular Telangiectasia Type 2 (MacTel)

Who this might be right for
Idiopathic Juxtafoveal Telangiectasia
Paul S. Bernstein 8
Testing effectiveness (Phase 2)Study completedNCT04729972
What this trial is testing

Safety Study to Evaluate Bilateral CNTF Implants in Subjects With MacTel Type 2

Who this might be right for
Macular Telangiectasia Type 2
Neurotech Pharmaceuticals 33
Load More Results